Normativa sobre la utilización de fármacos inhalados

Archivos de Bronconeumologia

Volumn 36, Issue 1, 2000, Pages 34-43

  Giner, J ^a   Basualdo, L V ^b   Casan, P ^a   Hernandez C ^c   Macian V ^f   Martanezd I ^d   Mengibar A ^e  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b HOSPITAL DE GALDAKAO   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BUDESONIDE; CARBUTEROL; CROMOGLYCATE DISODIUM; FENOTEROL; FLUTICASONE; FORMOTEROL; HEXOPRENALINE; IPRATROPIUM BROMIDE; NEDOCROMIL SODIUM; RIBAVIRIN; SALBUTAMOL; SALMETEROL; TERBUTALINE; RESPIRATORY TRACT AGENT;

DRUG USE; HUMAN; PRACTICE GUIDELINE; REVIEW; AEROSOL; ARTICLE; INHALATIONAL DRUG ADMINISTRATION; NEBULIZER; POWDER; PULMONOLOGY; SPAIN; THORAX SURGERY;

ADMINISTRATION, INHALATION; AEROSOLS; HUMANS; NEBULIZERS AND VAPORIZERS; POWDERS; PULMONARY DISEASE (SPECIALTY); RESPIRATORY SYSTEM AGENTS; SPAIN; THORACIC SURGERY;

EID: 85018807782     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2896(15)30231-3     Document Type: Article

References (27)

1. Aerosol Concensus Statement. Chest 1991; 100: 1106-1109.
2. Agustí AGN, Usuetti P, Roca J, Montserrat JM, Rodríguez Roisín R, Agutí Vidal V. Asma bronquial y broncodilatadores en aerosol: empleo incorrecto en nuestro medio. Med Clin (Barc) 1983; 81: 893-894.
3. Boe J, Stiksa G, Svensson K, Asbrink E. New method of evaluating patient preference for different inhalation delivery systems. Ann Allergy 1992; 68: 255-260.
4. Brain JD, Valberg PA. Deposition of aerosol in the respiratory tract. Am Rev Respir Dis 1979; 120: 1325-1373
5. Bishop MJ, Larson RP, Buschman DL. Metered dose inhaler aerosol characteristics are affected by endotracheal tube actuator/adapter used. Anesthesiology 1990; 73: 1263-1265.
6. Dolovich M, Ruffin RE, Roberts R, Newhouse MT. Optimal delivery of aerosols from metered dose inhalers. Chest 1981; 80 (Supl): 911.
7. Gay PC, Patel HG, Nelson SB, Guilles B, Hubmary RD. Metered dose inhalers for bronchodilator delivery in intubated, mechanically ventilated patients. Chest 1991; 99: 66-71.
8. Green M, Molema J, Thompson Ph, Tashkin D, Bleecker ER. Asthma and the ozone layer. Brit J Clinical Practice 1995; 79: 1-36.
9. Hess D, Horney D, Snyder. Medication-delivery performance of eight small-volme, hand-held nebulizers: effects of diluent volume, gas flowrate and nebulizer model. Respir Care 1989; 34: 717-723.
10. Hess D. How should bronchodilators be administered to patients on ventilators? Respir Care 1991; 36: 377-394.
11. König P. Spacer devices used with metered-dose inhalers. Breakthrough or gimmick? Chest 1985; 88: 276-284.
12. Madsen EB, Bundgaard A, Hidinger KG. Cumulative dose response study comparing terbutaline pressurised aerosol administered in a pear shaped spacer and terbutaline in a nebulized solution. Eur J Clin Pharmacol 1982; 23: 27-30.
13. Mayos M, Casan P, Heredia JL, Sanchís J. Cámara de aerosol para pacientes con inhalación incorrecta. Arch Bronconeumol 1989; 23: 118-122.
14. McFadden ER. Inhaled aerosol bronchodilators. Baltimore: Williams and Wilkins, 1986.
15. Moren F. Drug deposition of pressurized inhalation aerosol. Influence of actuator tubo design. Int J Pharm 1987; 1: 205-212.
16. Morgan MDL, Singh BV, Frame MF, Williams SJ. Terbutaline aerosol given through a pear-spacer in acute severe asthma. Br Med J 1982; 285: 849-850.
17. Newman SP, Pavia D, Moren F, Sheman NF, Clarke SW. Depositon of pressurised aerosols in the human respiratory tract. Thorax 1981; 36: 52-55.
18. Newman SP, Millar A, Lennard T, Moren F, Clarke S. Improvement of pressurised aerosol deposition with nebuhaler spacer device. Thorax 1984; 39: 935-941.
19. Newman SP. Aerosol generators and delivery sistems respiratory. Crit Care 1990; 36: 939-951.
20. Newman SP, Clarke S W. Inhalation devices and techniques. En: Clark TJH, Godfrey S, Lee TH, editores. Asma. Londres. Chapman and Hall, 1992; 469-505.
21. Pedersen S. Aerosol treatment of bronchoconstriction in children with or without a tube space. N Engl J Med 1983; 308: 1328-1330.
22. Perry R, Shinto R, Wong F, Derpars J, Light R. Nebulizer vs spacer for bronchodilator delivery in patients hospitalized for acute exacerbations of COPD. Chest 1989; 96: 1.241-1.246.
23. Plaza V, Casan P, Diego A, Galdiz JB, Löpez Viñas A, Manresa F. Recomendaciones para la utilización de fármacos inhalados. Arch Bronconeumol 1996; 32 (Supl): 8-9.
24. Serra J, Comella A, Casas JC, Plaza V, Brugues J. Cámara de inhalation: ¿alternativa al inhalador conventional? Med Clin (Barc) 1993; 101: 125-127.
25. Shim C, Williams MH. The adequacy of inhalation of aerosol from canister nebulizers. Am J Med 1980; 69: 891-894
26. Toogood JH, Baskerville J, Jennings B, Lefcoe NM, Johansson SA. Use of spacer to facilitate inhaled corticosteroid treatment of asthma. Am Rev Respir Dis 1984; 129: 723-729.
27. Toogod, JH, Jennings B, Basherville J, Hohansson SA. Clinical use of spacer systems for corticosteroid inhalation therapy: a preliminary analysis. Eur J Respir Dis 63 1982; 122: 100-107.